NCT00669994View on ClinicalTrials.gov

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

October 31, 2003

Conditions
Urinary Tract Infection
Interventions
DRUG

Ciprofloxacin

Cipro XR 500 mg tablets taken once daily

Trial Locations (31)

13031

Camillus

15009

Beaver

19040

Hatboro

19053

Feasterville

29485

Summerville

33024

Pembroke Pines

33761

Clearwater

35124

Pelham

35205

Birmingham

35242

Birmingham

47714

Evansville

53715

Madison

78209

San Antonio

84088

West Jordan

84102

Salt Lake City

84107

Murray

84109

Salt Lake City

84121

Salt Lake City

85023

Phoenix

90806

Long Beach

91342

Sylmar

92653

Laguna Hills

92886

Yorba Linda

93401

San Luis Obispo

92182-4701

San Diego

94403-4398

San Mateo

06001

Avon

01757

Milford

48073-6769

Royal Oak

07202-3672

Elizabeth

07733

Holmdel

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00669994 - Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections | Biotech Hunter | Biotech Hunter